- Obesity and Metabolism
- Vav3, a GEF for RhoA, Plays a Critical Role under High Glucose Conditions
-
Jie Sha, Jungsik Na, Jung Ok Lee, Nami Kim, Soo Kyung Lee, Ji Hae Kim, Ji Wook Moon, Su Jin Kim, Hye Jeong Lee, Jong-Il Choi, Sun Hwa Park, Hyeon Soo Kim
-
Endocrinol Metab. 2014;29(3):363-370. Published online September 25, 2014
-
DOI: https://doi.org/10.3803/EnM.2014.29.3.363
-
-
4,216
View
-
39
Download
-
8
Web of Science
-
7
Crossref
-
Abstract
PDFPubReader
- Background
The role of small GTPase molecules is poorly understood under high glucose conditions. MethodsWe analyzed the expression pattern of Vav3 in skeletal muscle C2C12 cells under high glucose culture condition with reverse transcription-polymerase chain reaction and Western blot analysis. We also measured glucose uptake using isotope-labelled glucose. ResultsWe showed that expression of Vav3 (a guanine nucleotide exchange factor for RhoA) increased. mRNA and protein levels in skeletal muscle C2C12 cells under high glucose conditions. The AMP-activated protein kinase (AMPK) activator AMPK agonist 5-aminoimidazole-4-carboxy-amide-1-d-ribofuranoside (AICAR) suppressed high glucose-induced Vav3 induction. In addition, exposure of cells to high glucose concentration increased the phosphorylation of PAK-1, a molecule downstream of RhoA. The phosphorylation of paxillin, a downstream molecule of PAK-1, was also increased by exposure to high glucose. Phosphorylation of these molecules was not observed in the presence of AICAR, indicating that AMPK is involved in the RhoA signal pathway under high glucose conditions. Knock down of Vav3 enhances metformin-mediated glucose uptake. Inhibition of AMPK blocked the increases of Vav3 knock down-induced glucose uptake. Metformin-mediated Glut4 translocation was also increased by Vav3 knock-down, suggesting that Vav3 is involved in metformin-mediated glucose uptake. ConclusionThese results demonstrate that Vav3 is involved in the process of metformin-mediated glucose regulation.
-
Citations
Citations to this article as recorded by
- PAK1 inhibition increases TRIM21-induced PD-L1 degradation and enhances responses to anti-PD-1 therapy in pancreatic cancer
Kai Wang, Lili Yan, Xun Qiu, Huan Chen, Fengqiang Gao, Wenwen Ge, Zhengxing Lian, Xuyong Wei, Shuai Wang, Hong He, Xiao Xu Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease.2024; 1870(6): 167236. CrossRef - Peripheral origin exosomal microRNAs aggravate glymphatic system dysfunction in diabetic cognitive impairment
Lin Zhang, Dongna Li, Pengrong Yi, Jiangwei Shi, Mengqing Guo, Qingsheng Yin, Dingbin Liu, Pengwei Zhuang, Yanjun Zhang Acta Pharmaceutica Sinica B.2023; 13(7): 2817. CrossRef - A current overview of RhoA, RhoB, and RhoC functions in vascular biology and pathology
Robert Eckenstaler, Michael Hauke, Ralf A. Benndorf Biochemical Pharmacology.2022; 206: 115321. CrossRef - Rho Family GTPases and Rho GEFs in Glucose Homeostasis
Polly A. Machin, Elpida Tsonou, David C. Hornigold, Heidi C. E. Welch Cells.2021; 10(4): 915. CrossRef - Pharmacological Modulators of Small GTPases of Rho Family in Neurodegenerative Diseases
William Guiler, Addison Koehler, Christi Boykin, Qun Lu Frontiers in Cellular Neuroscience.2021;[Epub] CrossRef - Association of VAV2 and VAV3 polymorphisms with cardiovascular risk factors
Nuria Perretta-Tejedor, Javier Fernández-Mateos, Luis García-Ortiz, Manuel A. Gómez-Marcos, José I. Recio-Rodríguez, Cristina Agudo-Conde, Emiliano Rodriguez-Sánchez, Ana I. Morales, Francisco J. López-Hernández, José M. López-Novoa, Rogelio González-Sarm Scientific Reports.2017;[Epub] CrossRef - Articles in 'Endocrinology and Metabolism' in 2014
Won-Young Lee Endocrinology and Metabolism.2015; 30(1): 47. CrossRef
|